晚期年龄相关性黄斑变性临床研究中的影像学方案:萎缩分类共识会议的建议
该文总结2次萎缩分类共识会议(CAM)关于常规与先进影像模态在检测和量化晚期非新生血管性与新生血管性年龄相关性黄斑变性(AMD)所致萎缩中的建议。共识推荐在多模态影像方案中纳入彩色眼底照相、共焦眼底自发荧光、共焦近红外反射和高分辨率光密度断层扫描容积扫描,并定期采集。非新生血管性AMD研究基线及研究终点访视时彩色眼底照相可能足够,新生血管性AMD研究应纳入荧光素血管造影。
要点
- 检测、量化并监测萎缩进展的影像学方案应包括彩色眼底照相、共焦眼底自发荧光、共焦近红外反射和高分辨率光密度断层扫描容积扫描。
- 非新生血管性AMD研究(基线无活动性或消退性新生血管明确征象)中,基线及研究终点访视时彩色眼底照相可能足够。
- 新生血管性AMD研究应纳入荧光素血管造影(推荐基线和选定随访访视时进行),特定条件下可考虑吲哚菁绿血管造影。
核心结论
- 推荐在临床研究中采用多模态影像方法以最佳检测和测量萎缩及其相关特征。
- 确定最佳影像模态组合需要特定的验证研究,且随着未来新影像技术的出现,这些建议需要更新。
研究设计与样本
- 2次共识会议(萎缩分类会议[CAM])对用于检测和量化晚期非新生血管性和新生血管性AMD所致萎缩的常规与先进影像模态进行系统辩论。
- 由视网膜专家组成的小组参与。
- 方法为国际专家联盟基于大量临床病例的集体分析评估各影像模态的优缺点,并系统讨论每种模态在未來非新生血管性和新生血管性AMD研究中的作用。
主要发现
- 检测、量化并监测萎缩进展的影像学方案应包括彩色眼底照相(CFP)、共焦眼底自发荧光(FAF)、共焦近红外反射(NIR)和高分辨率光密度断层扫描(OCT)容积扫描。
- 这些图像应在整个研究期间定期采集。
- 非新生血管性AMD研究(基线无活动性或消退性新生血管明确征象)中,基线和研究终点访视时CFP可能足够。
- 研究期间任何访视时可能需要荧光素血管造影(FA)以评估新生血管。
- 特定条件下基線可考虑吲哚菁绿血管造影(ICG-A)。
关键数值与推荐
- 推荐在临床研究中采用多模态影像方法以最佳检测和测量萎缩及其相关特征。
- 非新生血管性AMD研究基线及研究终点访视时CFP可能足够。
- 研究期间任何访视时FA可能成为评估新生血管的必要手段。
- 特定条件下基线可考虑ICG-A。
- 新生血管性AMD研究推荐基线和选定随访访视时进行FA,特定条件下进行ICG-A。
临床怎么用
- 原文未据此给出推荐。
局限性
- 确定最佳影像模态组合需要特定的验证研究。
- 随着未来新影像技术的出现,这些建议需要更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To summarize the results of 2 consensus meetings (Classification of Atrophy Meeting [CAM]) on conventional and advanced imaging modalities used to detect and quantify atrophy due to late-stage non-neovascular and neovascular age-related macular degeneration (AMD) and to provide recommendations on the use of these modalities in natural history studies and interventional clinical trials. DESIGN: Systematic debate on the relevance of distinct imaging modalities held in 2 consensus meetings. PARTICIPANTS: A panel of retina specialists. METHODS: During the CAM, a consortium of international experts evaluated the advantages and disadvantages of various imaging modalities on the basis of the collective analysis of a large series of clinical cases. A systematic discussion on the role of each modality in future studies in non-neovascular and neovascular AMD was held. MAIN OUTCOME MEASURES: Advantages and disadvantages of current retinal imaging technologies and recommendations for their use in advanced AMD trials. RESULTS: Imaging protocols to detect, quantify, and monitor progression of atrophy should include color fundus photography (CFP), confocal fundus autofluorescence (FAF), confocal near-infrared reflectance (NIR), and high-resolution optical coherence tomography volume scans. These images should be acquired at regular intervals throughout the study. In studies of non-neovascular AMD (without evident signs of active or regressed neovascularization [NV] at baseline), CFP may be sufficient at baseline and end-of-study visit. Fluorescein angiography (FA) may become necessary to evaluate for NV at any visit during the study. Indocyanine-green angiography (ICG-A) may be considered at baseline under certain conditions. For studies in patients with neovascular AMD, increased need for visualization of the vasculature must be taken into account. Accordingly, these studies should include FA (recommended at baseline and selected follow-up visits) and ICG-A under certain conditions. CONCLUSIONS: A multimodal imaging approach is recommended in clinical studies for the optimal detection and measurement of atrophy and its associated features. Specific validation studies will be necessary to determine the best combination of imaging modalities, and these recommendations will need to be updated as new imaging technologies become available in the future.
引用
- Holz FG, Sadda SR, Staurenghi G, et al. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology. 2017. PMID: 28109563. doi:10.1016/j.ophtha.2016.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。